In Situ Forming Injectable Hydrogel For Encapsulation Of Nanoiguratimod And Sustained Release Of Therapeutics

BACKGROUND: Iguratimod (IGUR) is a novel disease-modifying antirheumatic drug used for treating rheumatoid arthritis (RA). To improve its bioavailability and to alleviate gastrointestinal side effects, we changed the formulation into nanoiguratimod-loaded hydrogel (NanoIGUR-loaded hydrogel) composit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Zhenzhen, Tao, Cheng, Sun, Lin, Qi, Shengbei, Le, Yuan, Wang, Jiexin, Li, Changhong, Liu, Xiangyuan, Zhang, Jianjun, Zhao, Jinxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6847989/
https://www.ncbi.nlm.nih.gov/pubmed/31806967
http://dx.doi.org/10.2147/IJN.S214507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6847989/
https://www.ncbi.nlm.nih.gov/pubmed/31806967
http://dx.doi.org/10.2147/IJN.S214507

Ejemplares similares